Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last SFr.0.50 CHF
Change Today 0.00 / 0.00%
Volume 318.9K
CYTN On Other Exchanges
As of 11:43 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Harry Welten MBA

Chief Financial Officer, Executive Vice President and Member of Executive Board, Cytos Biotechnology AG
AgeTotal Calculated CompensationThis person is connected to 22 board members in 3 different organizations across 4 different industries.

See Board Relationships


Dr. Harry Welten, MBA, has been Chief Financial Officer and Executive Vice President of Cytos Biotechnology AG since August 2010 and as its Member of Executive Board since August 29, 2011. Dr. Welten served as Chief Financial Officer of Arpida AG since August 2001 and also as its Senior Vice President. He serves as a Director of Anokion SA. He has been a Director of Biognosys AG since 2011 and Biotie Therapies AG since January 2009.

Corporate Headquarters*

Wagistrasse 25
Schlieren, Zurich 8952


Phone: 41 44 733 47 47
Fax: 41 44 733 47 40

Board Members Memberships*



There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CYTN:SW SFr.0.50 CHF 0.00


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CYTOS BIOTECHNOLOGY AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at